CRYSTAL-STRUCTURE AT 3.5 ANGSTROM RESOLUTION OF HIV-1 REVERSE-TRANSCRIPTASE COMPLEXED WITH AN INHIBITOR (SCIENCE, VOL 256, PG 1783, 1992)

被引：0

作者：

STEITZ, TA ^{[1
]}

KOHLSTAEDT, LA ^{[1
]}

WANG, J ^{[1
]}

FRIEDMAN, JM ^{[1
]}

RICE, PA ^{[1
]}

机构：

[1] YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM & CHEM,NEW HAVEN,CT 06511

来源：

SCIENCE | 1993年 / 259卷 / 5093期

关键词：

D O I：

10.1126/science.259.5093.295

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：295 / 295

页数：1

共 36 条

[21] THE X-RAY CRYSTAL-STRUCTURE OF THE SULFONATED AZO-DYE CONGO-RED, A NONPEPTIDIC INHIBITOR OF HIV-1 PROTEASE WHICH ALSO BINDS TO REVERSE-TRANSCRIPTASE AND AMYLOID PROTEINS
OJALA, WH
OJALA, CR
GLEASON, WB
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1995, 6 (01): : 25 - 33
[22] TEMPLATE-DIRECTED PAUSING OF DNA-SYNTHESIS BY HIV-1 REVERSE-TRANSCRIPTASE DURING POLYMERIZATION OF HIV-1 SEQUENCES INVITRO (VOL 268, PG 9793, 1993)
KLARMANN, GJ
SCHAUBER, CA
PRESTON, BD
JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (18) : 13764 - 13764
[23] CRYSTAL-STRUCTURE AT 1.9-ANGSTROM RESOLUTION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-II PROTEASE COMPLEXED WITH L-735,524, AN ORALLY BIOAVAILABLE INHIBITOR OF THE HIV PROTEASES
CHEN, ZG
LI, Y
CHEN, E
HALL, DL
DARKE, PL
CULBERSON, C
SHAFER, JA
KUO, LC
JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (42) : 26344 - 26348
[24] Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1 (vol 97, pg 4228, 2008)
Gupta, Kavita M.
Pearce, Serena M.
Poursaid, Azadeh E.
Aliyar, Hyder A.
Tresco, Patrick A.
Mitchnik, Mark A.
Kiser, Patrick F.
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (03) : 1199 - 1199
[25] Crystal structure of HIV-1 reverse transcriptase (RT)/dsDNA/non-nucleoside inhibitor complex for understanding inhibition and drug resistance
Das, K.
Martinez, S. E.
Arnold, E.
ANTIVIRAL THERAPY, 2011, 16 : A56 - A56
[26] A new potent HIV-1 reverse transcriptase inhibitor: A synthetic peptide derived from the interface subunit domains (vol 274, pg 24941, 1999)
Morris, May C.
Mery, Jean
Heitz, Frederic
Goody, Roger S.
Divita, Gilles
JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (16) : 6658 - 6658
[27] Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients (vol 14, pg 791, 2000)
Khanna, N
Klimkait, T
Schiffer, V
Irigoyen, J
Telenti, A
Hirschel, B
Battegay, M
AIDS, 2000, 14 (09) : 1297 - 1297
[28] Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1 (vol 161, pg 461, 2014)
Lennox, J. L.
Landovitz, R. J.
Ribaudo, H. J.
Ofotokun, I
Na, L. H.
Godfrey, C.
ANNALS OF INTERNAL MEDICINE, 2014, 161 (07)
[29] Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114 (vol 363, pg 161, 2006)
Kovalevsky, Andrey Y.
Liu, Fengling
Leshchenko, Sofiya
Ghosh, Arun K.
Louis, John M.
Harrison, Robert W.
Weber, Irene T.
JOURNAL OF MOLECULAR BIOLOGY, 2007, 365 (03) : 901 - 901
[30] Structure of HOE/BAY 793 complexed to human immunodeficiency virus (HIV-1) protease in two different crystal forms. Structure/function relationship and influence of crystal packing (vol 248, pg 313, 1997)
LangeSavage, G
Berchtold, H
Liesum, A
Budt, KH
Peyman, A
Knolle, J
Sedlacek, J
Fabry, M
Hilgenfeld, R
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 249 (03): : 912 - 912

← 1 2 3 4 →